FDA Inspection 1059005 — Ipsen BioPharm Ltd
The FDA completed an inspection of Ipsen BioPharm Ltd on Jul 6, 2018 in Wrexham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wrexham (United Kingdom)